Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Current Market Overview
- Macroeconomic Factors Analysis
- Government Policy and Regulation
- Technological Infrastructure and Digital Readiness
- Global Trade and Supply Chain Dynamics
- Impact of U.S. Tariffs
- Porter's Five Forces Analysis
- Potential for New Entrants (Moderate to High)
- Bargaining Power of Suppliers (Low to Moderate)
- Bargaining Power of Buyers (High)
- Threat of Substitute Products or Services (Low to Moderate)
- Industry Level of Competitiveness (High)
- AI's Impact on the Pharmaceutical Value Chain
- Drug Discovery and Preclinical Development: Accelerated Innovation
- Clinical Trials: Smarter Design and Execution
- Manufacturing and Supply Chain: Intelligent Operations
- Regulatory Affairs and Compliance: Automation and Accuracy
- Commercialization and Market Access: Data-Driven Strategies
- Post-Market Surveillance: Continuous Learning and Safety Monitoring
- Use Cases
- Use Case 1: Generative AI for Efficiency in Regulatory Submissions
- Use Case 2: Generative AI-Enabled R&D Assistant for Synthesis Routes
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Faster Drug Discovery and Development
- Increasing Adoption of AI in Clinical Trials
- Demand for Precision Medicine and AI Applications
- Market Restraints
- Regulatory and Ethical Concerns
- Data Challenges
- Market Opportunities
- Collaborations and Investments
- Increased Focus on Drug Discovery in Emerging Nations
- Advances of Generative AI in Molecular Design
Chapter 4 Regulatory Landscape
- Overview
- Regulatory Scenario in the U.S.
- Regulatory Scenario in Europe
- Regulatory Scenario in Japan
- Regulatory Scenario in China
- Other Countries
Chapter 5 Emerging Trends and Pipeline Analysis
- Emerging Trends
- Generative AI in Pharma
- Federated Learning
- Natural Language Processing
- Generative Adversarial Networks
- Pipeline Analysis
- Takeaways
- Patent Analysis
- Findings
Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- Market Breakdown, by Product Type
- Takeaways
- Software
- Services
- Market Breakdown, by Application
- Takeaways
- Drug Discovery and Development
- Clinical Trials
- Personalized Medicine
- Other Applications
- Geographic Breakdown
- Market Breakdown, by Region
- Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 7 Competitive Intelligence
- Takeaways
- Competitive Analysis
- Strategic Analysis
- Investment Landscape
Chapter 8 Sustainability in AI in the Pharmaceutical Industry: ESG Perspective
- Introduction to ESG
- Sustainability Trends and Initiatives
- ESG Risk Ratings
- Concluding Remarks
List of Tables
Summary Table: Global Market for AI in Pharmaceuticals, by Region, Through 2030
Table 1: Collaborations Between AI Software and Pharmaceutical Companies
Table 2: FDA AI/ML Initiatives and Milestones, 2014 and 2025
Table 3: EMA AI/ML Regulatory Development Timeline, 2021-2024
Table 4: Clinical Trial Data for AI in Pharmaceutical Drugs, 2025
Table 5: Granted Patents for AI in Pharmaceuticals, 2022-2025
Table 6: Global Market for AI in Pharmaceuticals, by Product Type, Through 2030
Table 7: Global Market for AI Software in Pharmaceuticals, by Region, Through 2030
Table 8: Global Market for Services in AI in Pharmaceuticals, by Region, Through 2030
Table 9: Global Market for AI in Pharmaceuticals, by Application, Through 2030
Table 10: AI Tools Used in Drug Discovery
Table 11: AI-Enabled Drugs Entering the Clinical Phase, 2025
Table 12: Global Market for AI in Drug Discovery and Development, by Region, Through 2030
Table 13: Partnerships Between Pharmaceutical and Technology Companies, 2023-2025
Table 14: Advantages and Disadvantages of Using AI in Clinical Trials
Table 15: Global Market for AI in Pharmaceuticals for Clinical Trial Applications, by Region, Through 2030
Table 16: Applications of ML in Pharmacogenomics
Table 17: Global Market for AI in Pharmaceuticals for Personalized Medicine, by Region, Through 2030
Table 18: Global Market for Other Applications of AI in Pharmaceuticals, by Region, Through 2030
Table 19: Global Market for AI in Pharmaceuticals, by Region, Through 2030
Table 20: North American Market for AI in Pharmaceuticals, by Product Type, Through 2030
Table 21: North American Market for AI in Pharmaceuticals, by Application, Through 2030
Table 22: North American Market for AI in Pharmaceuticals, by Country, Through 2030
Table 23: European Market for AI in Pharmaceuticals, by Product Type, Through 2030
Table 24: European Market for AI in Pharmaceuticals, by Application, Through 2030
Table 25: European Market for AI in Pharmaceuticals, by Country, Through 2030
Table 26: Asia-Pacific Market for AI in Pharmaceuticals, by Product Type, Through 2030
Table 27: Asia-Pacific Market for AI in Pharmaceuticals, by Application, Through 2030
Table 28: Asia-Pacific Market for AI in Pharmaceuticals, by Country, Through 2030
Table 29: RoW Market for AI in Pharmaceuticals, by Product Type, Through 2030
Table 30: RoW Market for AI in Pharmaceuticals, by Application, Through 2030
Table 31: RoW Market for AI in Pharmaceuticals, by Sub-Region, Through 2030
Table 32: Leading Companies in the Global Market for AI in Pharmaceuticals, 2024
Table 33: Agreements, Collaborations and Partnerships in the Market for AI in Pharmaceuticals, 2022-2025
Table 34: M&A in the AI in Pharmaceuticals Industry, 2024-2025
Table 35: Recent Investments in the AI in Pharmaceuticals Industry, 2024 and 2025
Table 36: ESG Risk Rankings for AI in Pharmaceuticals Companies, 2025*
Table 37: Information Sources Used in this Report
Table 38: Abbreviations Used in this Report
Table 39: AiCure: Company Snapshot
Table 40: AiCure: Product Portfolio
Table 41: AiCure: News/Key Developments, 2024
Table 42: Atomwise Inc.: Company Snapshot
Table 43: Atomwise Inc.: Product Portfolio
Table 44: Atomwise Inc.: News/Key Developments, 2022
Table 45: BenevolentAI: Company Snapshot
Table 46: BenevolentAI: Product Portfolio
Table 47: BenevolentAI: News/Key Developments, 2022-2025
Table 48: Google DeepMind: Company Snapshot
Table 49: Google DeepMind: Product Portfolio
Table 50: Google DeepMind: News/Key Developments, 2024 and 2025
Table 51: Healx: Company Snapshot
Table 52: Healx: Product Portfolio
Table 53: Healx: News/Key Developments, 2023 and 2024
Table 54: Iktos: Company Snapshot
Table 55: Iktos: Product Portfolio
Table 56: Iktos: News/Key Developments, 2023-2025
Table 57: Insilico Medicine: Company Snapshot
Table 58: Insilico Medicine: Product Portfolio
Table 59: Insilico Medicine: News/Key Developments, 2023-2025
Table 60: InveniAI LLC.: Company Snapshot
Table 61: InveniAI LLC.: Product Portfolio
Table 62: InveniAI LLC.: News/Key Developments, 2021-2024
Table 63: Nvidia Corp.: Company Snapshot
Table 64: Nvidia Corp.: Financial Performance, FY 2023 and 2024
Table 65: Nvidia Corp.: Product Portfolio
Table 66: Nvidia Corp.: News/Key Developments, 2023-2025
Table 67: PathAI Inc.: Company Snapshot
Table 68: PathAI Inc.: Product Portfolio
Table 69: PathAI Inc.: News/Key Developments, 2024 and 2025
Table 70: Recursion: Company Snapshot
Table 71: Recursion: Financial Performance, FY 2023 and 2024
Table 72: Recursion: Product Portfolio
Table 73: Recursion: News/Key Developments, 2024 and 2025
Table 74: Schrödinger Inc.: Company Snapshot
Table 75: Schrödinger Inc.: Financial Performance, FY 2023 and 2024
Table 76: Schrödinger Inc.: Product Portfolio
Table 77: Schrödinger Inc.: News/Key Developments, 2023 and 2024
Table 78: SyrenCloud Inc.: Company Snapshot
Table 79: SyrenCloud Inc.: Product Portfolio
Table 80: Tempus AI Inc.: Company Snapshot
Table 81: Tempus AI Inc.: Financial Performance, FY 2023 and 2024
Table 82: Tempus AI Inc.: Product Portfolio
Table 83: Tempus AI Inc.: News/Key Developments, 2023-2025
Table 84: XtalPi Inc.: Company Snapshot
Table 85: XtalPi Inc.: Financial Performance, FY 2023 and 2024
Table 86: XtalPi Inc.: Product Portfolio
Table 87: XtalPi Inc.: News/ Key Developments, 2024 and 2025
Table 88: Emerging Startups in the Market for AI in Pharmaceuticals
List of Figures
Summary Figure: Global Market Shares of AI in Pharmaceuticals, by Region, 2024
Figure 1: Applications of AI in the Drug Development and Distribution Life Cycle
Figure 2: Porter’s Five Forces Analysis: AI in Pharmaceuticals Market
Figure 3: Applications of AI in the Pharmaceutical Value Chain
Figure 4: Market Dynamics of AI in Pharmaceuticals
Figure 5: Emerging Technologies of AI in the Pharmaceutical Market
Figure 6: Granted Patents for AI in Pharmaceuticals, by Year, 2021-2025
Figure 7: Global Market Shares of AI in Pharmaceuticals, by Product Type, 2024
Figure 8: Global Market Shares of AI Software in Pharmaceuticals, by Region, 2024
Figure 9: Global Market Shares of Services for AI in Pharmaceuticals, by Region, 2024
Figure 10: Global Market Shares of AI in Pharmaceuticals, by Application, 2024
Figure 11: Role of AI in Drug Discovery
Figure 12: Global Market Shares of AI in Drug Discovery and Development, by Region, 2024
Figure 13: Global Market Shares of AI in Pharmaceuticals for Clinical Trial Applications, by Region, 2024
Figure 14: Global Market Shares of AI in AI in Pharmaceuticals for Personalized Medicine, by Region, 2024
Figure 15: Global Market Shares of Other Applications of AI in Pharmaceuticals, by Region, 2024
Figure 16: Global Market Shares of AI in Pharmaceuticals, by Region, 2024
Figure 17: North American Market Shares of AI in Pharmaceuticals, by Product Type, 2024
Figure 18: North American Market Shares of AI in Pharmaceuticals, by Application, 2024
Figure 19: North American Market Shares of AI in Pharmaceuticals, by Country, 2024
Figure 20: European Market Shares of AI in Pharmaceuticals, by Product Type, 2024
Figure 21: European Market Shares of AI in Pharmaceuticals, by Application, 2024
Figure 22: European Market Shares of AI in Pharmaceuticals, by Country, 2024
Figure 23: Asia-Pacific Market Shares of AI in Pharmaceuticals, by Product Type, 2024
Figure 24: Asia-Pacific Market Shares of AI in Pharmaceuticals, by Application, 2024
Figure 25: Asia-Pacific Market Shares of AI in Pharmaceuticals, by Country, 2024
Figure 26: RoW Market Shares of AI in Pharmaceuticals, by Product Type, 2024
Figure 27: RoW Market Shares of AI in Pharmaceuticals, by Application, 2024
Figure 28: RoW Market Shares of AI in Pharmaceuticals, by Sub-Region, 2024
Figure 29: Biopharma AI Investment, 2019-2024
Figure 30: Nvidia Corp.: Revenue Share, by Business Unit, FY 2024
Figure 31: Nvidia Corp.: Revenue Share by Country/Region, FY 2024
Figure 32: Schrödinger Inc.: Revenue Share, by Business Unit, FY 2024
Figure 33: Schrödinger Inc.: Revenue Share, by Country/Region, FY 2024
Figure 34: Tempus AI Inc.: Revenue Share, by Business Unit, FY 2024
Figure 35: XtalPi Inc.: Revenue Share, by Business Unit, FY 2024
Figure 36: XtalPi Inc.: Revenue Share, by Country/Region, FY 2024
